In December 2015, 34 patients’ groups from across Latin America gathered in Buenos Aires (Argentina) and actively participated in the Latin American Patient Advocacy Groups’ Summit on Biotherapeutics, co-hosted by IAPO and the Global Alliance for Patient Access (GAfPA), sponsored by AbbVie.
No todos los actores involucrados en el tema de salud, saben argumentar o exponer sus legítimas necesidades y derechos ante las autoridades gubernamentales en el Mundo y muy particularmente en latino América.
There was widespread consensus that drug regulators and patient groups need to work more closely together in Latin America at a multi-stakeholder seminar held in Rio de Janeiro, Brazil yesterday.
